SS Innovations International (NASDAQ:SSII) CEO Srivastava Sudhir Sells 33,333 Shares of Stock

SS Innovations International, Inc. (NASDAQ:SSII) CEO Srivastava Sudhir sold 33,333 shares of the business’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $3.00, for a total value of $99,999.00. Following the completion of the transaction, the chief executive officer directly owned 108,520,928 shares in the company, valued at approximately $325,562,784. This represents a 0.03% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

SS Innovations International Price Performance

NASDAQ SSII opened at $3.30 on Friday. The business’s fifty day moving average is $3.64 and its 200-day moving average is $4.05. The stock has a market capitalization of $661.25 million, a price-to-earnings ratio of -55.00 and a beta of -1.94. SS Innovations International, Inc. has a one year low of $3.11 and a one year high of $10.00.

SS Innovations International (NASDAQ:SSII) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.01) EPS for the quarter. SS Innovations International had a negative return on equity of 26.77% and a negative net margin of 23.73%.The company had revenue of $13.94 million during the quarter.

Institutional Trading of SS Innovations International

Hedge funds and other institutional investors have recently modified their holdings of the business. Eversept Partners LP purchased a new stake in shares of SS Innovations International during the fourth quarter valued at approximately $428,000. AlphaCentric Advisors LLC purchased a new stake in shares of SS Innovations International during the fourth quarter valued at $284,000. Inspire Investing LLC increased its holdings in SS Innovations International by 124.4% in the 4th quarter. Inspire Investing LLC now owns 82,773 shares of the company’s stock worth $470,000 after buying an additional 45,886 shares in the last quarter. Geode Capital Management LLC bought a new position in SS Innovations International during the 2nd quarter valued at about $122,000. Finally, Vontobel Holding Ltd. purchased a new stake in shares of SS Innovations International during the 4th quarter valued at about $116,000.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. Loop Capital set a $7.00 target price on SS Innovations International in a research note on Wednesday, June 3rd. Wall Street Zen upgraded shares of SS Innovations International from a “sell” rating to a “hold” rating in a research report on Sunday, June 28th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of SS Innovations International in a research report on Friday, July 17th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has an average rating of “Sell” and a consensus price target of $7.00.

About SS Innovations International

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.